Manufacturer of advanced haemostatic products NOBR started exporting its products to South Africa

New Biomedical Solutions (NOBR), a developer and manufacturer of advanced biopolymer-based hemostatic products, has signed its first contract to supply the entire ELLARGA range to South Africa in 2019.

"In order to enter international markets, New Biomedical Solutions has carried out certification procedures for its manufacturing processes according to the international standard ISO 13485. And already in 2019, the company signed the first contract to supply its own products to South Africa and made the first shipments to a new customer," said the company's representative.

He added that at the moment the NOBR management is considering expanding the geography of export deliveries and is already negotiating with representatives from Africa, Mexico, Malaysia, Vietnam.

"ELLARGA"

"ELLARGA" - is a hemostatic agent, which can leave external, including arterial, potentially fatal bleeding in two minutes. The hemostatic effect is achieved due to the local concentration of blood components and binding of chitosan molecules to negatively charged erythrocytes.

"Ellarga consists of up to 75% of chitosan, a substance found in the shell of crustaceans such as shrimps. On contact with blood, chitosan turns into a gel and prevents blood from leaking. This natural polymer has long been used in medicine. It is hypoallergenic, has natural antibacterial properties and is biodegradable - self-absorbable medical devices are made of chitosan fibers.

At the same time the use of this product does not require medical skills, so the drug can be used to provide first aid and emergency care for bleeding wounds and vessel damage, as well as in the hospital to stop bleeding when traditional methods of hemostasis are ineffective.

The ability to provide medical care in a few seconds for extremely dangerous bleeding is a factor that determines the innovativeness of the Russian development. The preparations make it possible to help the injured right on the scene, whether it is a car accident or a sports injury.

ELLARGA" development is an easy-to-use natural and safe product. If necessary, the product should be placed in the wound, then a bandage should be applied and pressure should be applied to the injured area. It will then transform into a gel and immediately perform its function, while ELLARGA acts irrespective of the physiological mechanisms of blood clotting - it will even stop chilled blood (in hypothermia) and blood containing anticoagulants such as warfarin.

Means "ELLARGA" is available in two forms:

- 3g, 8g, 15g powder. Packaged active ingredient in pure form. It is compact and economical in use;

- Bandage size 2,5x100cm and 7,5x150cm. Hemostatic powder is applied on both sides of the bandage base and is not washed out, even in case of heavy bleeding. Quickly detachable from packaging and uncoil.

Each ELLARGA product can fit in any first aid kit.

Participation in international events

NOBR specialists were able to build an understanding of the needs of selected local overseas markets and make business contacts after participating in major international medical exhibitions - Arab Health in Dubai in 2018 and 2019 and MEDICA in 2019, where they received positive feedback on their products.

Arab Health

Arab Health is the Middle East's largest and the world's second largest healthcare and medical exhibition held in Dubai, UAE. Over 4,000 exhibitors from 68 countries annually visit the exhibition, including from the EEC, the Middle East, South East Asia and North Africa. The largest exposition is located on the area of 63513 square meters. m, divided into 23 spacious halls. Every year, the exhibition attracts about 97,000 visitors from around the world.

MEDICA

MEDICA is an international medical forum that takes place annually in Dusseldorf (Germany) and is among the ten best and most important exhibitions in the world in this field. The event is the largest exhibition of medical equipment, diagnostics and technologies. The forum gathers the leading specialists in medicine. In addition, the exhibition opens up new opportunities for business development and networking with partners.

In 2019, more than 120 thousand people visited MEDICA, of which 69% came from Europe, East Asia, North and South America, Africa and Australia.

ABOUT NOBR.

New Biomedical Solutions (NOBR), founded in 2012, develops, manufactures and markets advanced biopolymer-based hemostatic products. The company was founded on the basis of a project that originated in the Formula Bio program of the Lomonosov Moscow State University Science Park. The company was supported by the NORB Foundation for Assistance to Innovations, the Zelenograd Nanotechnology Center, and the Ministry of Industry of the Russian Federation.